These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 2839553)

  • 21. Characterisation of a monoclonal antibody to von Willebrand factor as a potent inhibitor of ristocetin-mediated platelet interaction and platelet adhesion.
    Jorieux S; de Romeuf C; Samor B; Goudemand M; Mazurier C
    Thromb Haemost; 1987 Jun; 57(3):278-82. PubMed ID: 3116700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation.
    Ruggeri ZM
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):257-79. PubMed ID: 11686099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both increased and decreased platelet adhesion to thermally injured subendothelium is caused by denaturation of von Willebrand factor.
    Bos AN; Post MJ; de Groot PG; Sixma JJ; Borst C
    Circulation; 1993 Sep; 88(3):1196-204. PubMed ID: 8353881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor.
    Shenkman B; Linder N; Savion N; Tamarin I; Dardik R; Kennet G; German B; Varon D
    Pediatr Res; 1999 Feb; 45(2):270-5. PubMed ID: 10022601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the novel murine monoclonal anti-von Willebrand factor (vWf) antibody GUR76-23 which inhibits vWf interaction with alpha IIb beta 3 but not alpha v beta 3 integrin.
    Yokoyama K; Handa M; Oda A; Katayama M; Fujimura Y; Murata M; Kawai Y; Watanabe K; Ikeda Y
    Biochem Biophys Res Commun; 1997 May; 234(1):147-52. PubMed ID: 9168979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular interaction between platelet and vascular wall.
    Legrand YJ; Karniguian A; Fauvel F; Gutman N
    Blood Cells; 1983; 9(2):263-74. PubMed ID: 6229298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perturbation of cultured human vascular endothelial cells by phorbol ester or thrombin alters the cellular von Willebrand factor distribution.
    Reinders JH; Vervoorn RC; Verweij CL; van Mourik JA; de Groot PG
    J Cell Physiol; 1987 Oct; 133(1):79-87. PubMed ID: 3499441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Update on the role of vascular, plasmatic and cellular components in the regulation of the interaction of platelets with the subendothelium].
    Ordinas A; Escolar G; Bastida E; Castillo R
    Sangre (Barc); 1990 Dec; 35(6):425-32. PubMed ID: 2087660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Von Willebrand factor in the vessel wall mediates platelet adherence.
    Stel HV; Sakariassen KS; de Groot PG; van Mourik JA; Sixma JJ
    Blood; 1985 Jan; 65(1):85-90. PubMed ID: 3917314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward platelets.
    de Groot PG; Verweij CL; Nawroth PP; de Boer HC; Stern DM; Sixma JJ
    Arteriosclerosis; 1987; 7(6):605-11. PubMed ID: 3318780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. von Willebrand factor and the blood vessel wall.
    Sixma JJ; de Groot PG
    Mayo Clin Proc; 1991 Jun; 66(6):628-33. PubMed ID: 2046402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of platelet-vessel wall interaction. Platelet receptors, monoclonal antibodies, and synthetic peptides.
    Ruggeri ZM
    Circulation; 1990 Jan; 81(1 Suppl):I35-9; discussion I40-1. PubMed ID: 2403866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.
    Lawrence JB; Kramer WS; McKeown LP; Williams SB; Gralnick HR
    J Clin Invest; 1990 Nov; 86(5):1715-22. PubMed ID: 2243140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VIII/von Willebrand factor.
    Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1510-8. PubMed ID: 2451878
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of platelet membrane glycoproteins and von Willebrand factor in adhesion of platelets to subendothelium and collagen.
    Sakariassen KS; Fressinaud E; Girma JP; Meyer D; Baumgartner HR
    Ann N Y Acad Sci; 1987; 516():52-65. PubMed ID: 3501938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of membrane glycoproteins in the interaction of blood platelets with the vessel wall--the study on platelet adhesion to in vitro cultured subendothelial matrix.
    Kawai Y; Handa M; Nagai H; Kamata T; Anbo H; Kawano K; Araki Y; Yamamoto M; Ikeda Y; Watanabe K
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1312-21. PubMed ID: 2629457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved adhesion and proliferation of human endothelial cells on polyethylene precoated with monoclonal antibodies directed against cell membrane antigens and extracellular matrix proteins.
    Dekker A; Poot AA; van Mourik JA; Workel MP; Beugeling T; Bantjes A; Feijen J; van Aken WG
    Thromb Haemost; 1991 Dec; 66(6):715-24. PubMed ID: 1796417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coating conditions matter to collagen matrix formation regarding von Willebrand factor and platelet binding.
    Mendelboum Raviv S; Szekeres-Csiki K; Jenei A; Nagy J; Shenkman B; Savion N; Harsfalvi J
    Thromb Res; 2012 Apr; 129(4):e29-35. PubMed ID: 22056526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ascorbic acid increases the thrombogenicity of cellular matrices.
    Hindriks GA; Sixma JJ; de Groot PG
    Thromb Haemost; 1991 Oct; 66(4):505-9. PubMed ID: 1796403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.